Tramadol-related deaths

Similar documents
Overview of drug-induced deaths in Europe - What does the data tell us?

Trends in injecting drug use in Europe

New trends in harm reduction in Europe: progress made challenges ahead

Public administration reforms and public sector performance in Central and Eastern Europe EU member states: in EU perspective

WCPT COUNTRY PROFILE December 2017 HUNGARY

WCPT COUNTRY PROFILE December 2017 SWEDEN

WCPT COUNTRY PROFILE December 2017 SERBIA

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

Smokefree Policies in Europe: Are we there yet?

Palliative nursing care of children and young people across Europe

Finnish international trade 2017 Figures and diagrams. Finnish Customs Statistics

Transmission, processing and publication of HBS 2015 data

Expert Peer Review for Carfentanil

Research paper: Legal treatment of the use of cannabis for medical purposes in the member states of the European Union

Meeting report, September 2005

A new scale to measure tobacco control activity in a country: data tables and questionnaire

Extrapolation and potential impact of IPHS deployment in Europe

Perspectives for information on alcohol use in the EU

'SECTION B EU PARTY. The following abbreviations are used:

Young people and drugs. Analytical report

Cross Border Genetic Testing for Rare Diseases

Review of Member State approaches to the Macrophyte and Phytobenthos Biological Quality Element in lakes

Present and potential perspectives for information on alcohol use in the EU

Youth attitudes on drugs. Analytical report

Media Release. Inaugural study reveals that more than one in four women in European and Central Asian prisons locked up for drug offences

Injecting trends in Austria including results of a systematic literature review on interventions aiming to influence the route of administration

Overview of European Consumption Databases

European Status report on Alcohol and Health

Fentanyl: trend-spotting overview and focus on deaths. Jane Mounteney EMCDDA

PARALLELISM AND THE LEGITIMACY GAP 1. Appendix A. Country Information

Project Meeting Prague

Manuel Cardoso RARHA Executive Coordinator Public Health MD Senior Advisor Deputy General-Director of SICAD - Portugal

31 countries (117 registries, 20 national) Increased coverage in countries with regional registries 50% European population Overall >20 million

SPECIAL EUROBAROMETER 332. Fieldwork: October 2009 Publication: May 2010

EU Market Situation for Poultry. Committee for the Common Organisation of the Agricultural Markets 20 April 2017

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT AND THE COUNCIL ON FOOD INGREDIENTS TREATED WITH IONISING RADIATION FOR THE YEAR 2012

LEBANON. WCPT COUNTRY PROFILE December 2018

EMCDDA-update HIV/HCV among people who inject drugs: situation and response

Update on EEA s near real time air quality data exchange

DENMARK. WCPT COUNTRY PROFILE December 2018

National level ICD 9-3 digit Nuts II european shortlist Croatia 1999/2000 From WHO ICD-10, 4 digit. 1999/2000 From WHO ICD-10, 4 digit

Alcohol-related harm in Europe and the WHO policy response

REPORT FROM THE COMMISSION TO THE EUROPEAN PARLIAMENT, THE COUNCIL, THE EUROPEAN ECONOMIC AND SOCIAL COMMITTEE AND THE COMMITTEE OF THE REGIONS

Yersiniosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods. Epidemiology

Medical Physicists Improving treatments, saving lives

EUROPEAN CITIZENS DIGITAL HEALTH LITERACY

GERMANY. WCPT COUNTRY PROFILE December 2018

Annual epidemiological report 2014 food- and waterborne diseases and zoonoses

Fresh fruit and vegetable production, trade, supply & consumption monitor in the EU-27 (covering ) With the support of:

European status report on alcohol and health Leadership, awareness and commitment

Drinking guidelines used in the context of early identification and brief interventions in Europe: overview of RARHA survey results

Emerging Risks Mapping of Activities in Member States. 67th Advisory Forum meeting, Utrecht, The Netherlands, 6 February 2018

Improving our capacity of identification and reporting on emerging trends. New methods and new areas of analysis

Bulgaria Bulgaria Drug Report 2018

Monthly measles and rubella monitoring report

Fieldwork: February March 2010 Publication: October 2010

EIIW Competitiveness Report on the EU Market

HIV/AIDS Joint Action HA-REACT

TEDDY. Teddy Network of Excellence. Annagrazia ALTAVILLA. Ph.D. Sciences Ethics LL.M. Health Law. diterranée

HIV/AIDS Think Tank meeting: EMCDDA report. Roland Simon, Klaudia Palczak, EMCDDA Luxembourg, 7 July 2015

Trichinellosis SURVEILLANCE REPORT. Annual Epidemiological Report for Key facts. Methods

Real Life, Real PD Survey

European Collaboration on Dementia. Luxembourg, 13 December 2006

real-time AQ data 2007 and plans for 2008

Where do EU Contries set the limit for low risk drinking.

CND UNGASS FOLLOW UP

ALCOHOL CONSUMPTION IN EUROPE; TRADITIONS, GENERATIONS, CULTURE AND POLICY

Attitudes of Europeans towards tobacco

Report. Survey conducted by TNS political & social

Proposal for the future operationalisation of GALI in social surveys

ERGP (12) 31 report on complaints handling ERGP REPORT ON THE ASSESSMENT OF COMPLAINT HANDLING PROCEDURES AND CONSUMER PROTECTION

EUROBAROMETER SPECIAL 332. Fieldwork: October 2009 Publication: May 2010

Malta Malta Drug Report 2018

Rheumatoid Arthritis Disease Burden and Access to Treatment

Global Trade in Lightweight Coated Writing Paper TradeData International Pty Ltd ( Page 1 5/18/2015

Special Eurobarometer 445. Report. Antimicrobial Resistance

Lithauania 5.1 % Country Drug Report 2017 THE DRUG PROBLEM IN LITHUANIA AT A GLANCE

508 the number of suicide deaths in deaths per 100,000 people was the suicide rate in Suicide deaths in 2013 by gender

25 September 2012 Early Years Pathfinder. misuse. Insert name of presentation on Master Slide. Presenter: Dr Sarah J Jones


Where we stand in EFORT

Outcome of proficiency test on EIA serology

Slovakia Slovakia Drug Report 2018

United Kingdom Veterinary Medicines Directorate Woodham Lane New Haw Addlestone Surrey KT15 3LS DECENTRALISED PROCEDURE

CNAPA Meeting Luxembourg September 2016

ANNUAL REPORT on surveillance for avian influenza in poultry in the EU in 2009

The Risk of Alcohol in Europe. Bridging the Gap June 2004

Identifying Europe s information needs for effective drug policy Lisbon, EMCCDA

Chemical Occurrence. Exposure Assessment. Food Consumption

EFSA s Concise European food consumption database. Davide Arcella Data Collection and Exposure Unit

IOSH No Time to Lose campaign: working together to tackle asbestos-related cancer #NTTLasbestos. Jonathan Hughes IOSH Vice President

Low risk drinking guidelines in Europe: results from RARHA survey E. Scafato, Istituto Superiore di Sanità, Italy

Estimating Smoking Related Cause of Death: a Cohort Approach Based on Lung Cancer Mortality in six European Countries

Transcription:

Tramadol-related deaths 216 Survey overview European joint DRD expert meeting Lisbon, 29-3 September 216 Isabelle Giraudon, Federica Mathis, Klaudia Palczak Paralel workshop Opioids, medicines and focus on Tramadol

2 Background and rational One of the missions of EMCDDA is to collect, register, analyse information on emerging trends in polydrug use, including combined use of licit and illicit psychoactive substances Particular attention to the medicines with high potential for misuse or for which alerts or signals of public health concerns have been reported Increase of UK tramadol-related deaths Ad-hoc data collection exercise launched in September 213: National DRD experts were asked to provide information on Tramadol related deaths registered in their countries. Data were provided by 9 countries. A new call for data was launched in 216

3 EMCDDA project on tramadol A new call for data was launched in 216 in view of the new EMCDDA project on misuses of tramadol in the context of poly drug use; To be implemented in 217 with selected number of MS (France, UK, Germany, Sweden) and in collaboration with the EMA in London; The objective of the study is to provide a comprehensive overview of tramadol, including its pharmacology and toxicology; availability and legal status, information on the levels of misuse and the risk and harms related with tramadol consumption, in the context of polydrug use, Based on the case studies but will strive to provide a European perspective where possible (EMCDDA and EMA) - e.g. data sets and today meeting as a first step

4 Methods Short questionnaire on: number of deaths age gender trends since 2 intentionality background on regulation

Results 13 countries provided data: Country 213 216 Austria P P Czech Republic Cyprus Estonia Finland P P P P P France Hungary P P Ireland Latvia P P P P Lithuania P P Slovakia P P Slovenia Spain Turkey P P P United Kingdom P P For 216 survey Cyprus, Hungary, and UK provided qualitative information only

Number of cases reported 6 Tramadol-related deaths 213 survey 12 11 1 8 6 4 2 18 16 13 12 2 1 1 UK FI CZ AT SK SI LV LT HU Country

Number of cases reported 7 Tramadol-related deaths most recent data (216 survey) 3 3 3 2 22 26 2 1 13 1 4 4 UK FI CZ AT SK SI LV LT HU FR IE EE ES CY Country

8 Tramadol-related deaths 213 vs 216 survey 12 11 1 8 212 214 6 4 2 21 16 13 12 26 24 2 1 1 1 UK FI CZ AT SK SI LV LT HU FR IE EE ES CY

Finland trend in the number of tramadolrelated deaths 9 3 3 2-28 according to 213 data 29-214 according to 216 data 3 26 2 24 23 21 22 2 1 14 14 14 1 8 6 4 3 2 1 2 21 22 23 24 2 26 27 28 29 21 211 212 213 214

Finland trend in the % of tramadol-related deaths (selection D) 1 2. 2-28 according to 213 data 22.9 23.1 2. 29-214 according to 216 data 1. 12.1 1.9 1.2 12. 13.9 13. 16. 16.1 1. 8.3. 3.3 4..4 1.. 2 21 22 23 24 2 26 27 28 29 21 211 212 213 214

Ireland trend in the number of tramadolrelated deaths (NDRDI) 11 3 2 22 26 26 2 1 13 13 14 1 11 8 8 11 8 2 2 21 22 23 24 2 26 27 28 29 21 211 212 213

Ireland trend in the % of tramadol-related deaths (NDRDI vs ST6 selection D) 12 16. 14. 13.8 12. 11.9 1. 1.1 9. 8. 6. 4. 6.3 4.8 3.9 4.8 6.9.3 3.7 6. 8. 2.. 1.8 2 21 22 23 24 2 26 27 28 29 21 211 212 213

Spain trend in the number of tramadol-related deaths 13 3 3 3 2 24 24 2 1 1 7 11 3 2 2 2 1 2 21 22 23 24 2 26 27 28 29 21 211 212 213 214

Spain trend in the % of tramadol-related deaths (selection D) 14 2 18 17.4 16 14 12 12.3 12.2 1 8 6 4. 6. 2 1.6.8 1.1 1.2. 2 21 22 23 24 2 26 27 28 29 21 211 212 213 214

Austria trend in the number of tramadolrelated deaths 1 14 13 12 12 11 1 1 8 6 7 7 4 4 4 4 2 2 21 22 23 24 2 26 27 28 29 21 211 212 213 214

Austria trend in the % of tramadol-related deaths (selection D) 16 9 8 8.1 7 6.9 6..1.1 4 3 2 3. 1.9 2.1 3.3 1 2 21 22 23 24 2 26 27 28 29 21 211 212 213 214

2 21 22 23 24 2 26 27 28 29 21 211 212 213 17 Trends comparison in the numbers of tramadolrelated deaths 3 3 2 2 1 1 Finland 1 2 8 3 4 6 14 14 14 24 3 23 21 26 22 3 3 2 2 1 1 Ireland 2 11 8 8 13 11 8 13 14 22 26 26 3 3 2 2 1 1 Spain Austria 2 1 3 7 2 11 2 24 24 2 22 24 26 28 21 212 214 3 3 3 2 2 1 1 1 12 7 4 4 11 13 7 2 22 24 26 28 21 212 214 4

18 Trends comparison in the numbers of tramadolrelated deaths 2. 2. 1. 1... 2 Finland Ireland 2. 2. 1. 1... Spain Austria 2 2 22 24 26 28 21 212 2 2 1 1 1 1 2 22 24 26 28 21 212 214 2 22 24 26 28 21 212 214

Finland age and gender profile of the tramadol-related deaths, 211 (N=18) 19 Slide 213 left for comparison. Note: n was 18, now for 211 n = 23 >=6 6-64 -9-4 4-49 4-44 3-39 3-34 2-29 2-24 1-19 <1 Female Male 83% males Mean age 27,8-1 -8-6 -4-2 2 4 6 8 1 Number of deaths reported

Finland age and gender profile of the tramadol-related deaths, 214 (N=22) 2 >=6 6-64 -9-4 4-49 4-44 3-39 3-34 2-29 2-24 1-19 <1 Female Male 82% males Mean age 31.3-1 -8-6 -4-2 2 4 6 8 1 Number of deaths reported

Ireland age and gender profile of the tramadolrelated deaths, 214 NDRDI (N=26) 21 >=6 6-64 -9-4 4-49 4-44 3-39 3-34 2-29 2-24 1-19 <1 Female Male 61.% males Mean age 4.7-1 -8-6 -4-2 2 4 6 8 1 Number of deaths reported

Spain age and gender profile of the tramadolrelated deaths, 214 (N=3) 22 >=6 6-64 -9-4 4-49 4-44 3-39 3-34 2-29 2-24 1-19 <1 Female Male 6% males Mean age 4. -1-8 -6-4 -2 2 4 6 8 1 Number of deaths reported

23 Changes in sales Increase in sales are reported by France, Ireland, Latvia Stable sales are reported in Finland, Lithuania, Hungary A reduction of % occurred in UK in 21 after a pick in 213 and 214 Caution: absolute numbers - do not take into account changes in the population

24 Notes on regulations at a national level Cyprus: In 22 Tramadol was included in the list of controlled substances. In 23, relevant regulations were issued; besides penalties for illegal trading, prescription rules were included, as well as a need of notification in case of addiction from the particular drug. Latvia: Despite the fact that there already were tramadol control actions (prescription to specific recipes, registration in the strict accountability register and inclusion of narcotic analgesics lists), changes in legislation were made in 214: tramadol was classified as psychotropic substance and it was included in the list of controlled substances. Spain: Tramadol is a legally commercialized pharmaceutical drug which requires medical prescription under the rules of the Spanish Ministry of Health, Social Services and Equality. However, apparently, this opiate derivative can be easily purchased in the Internet bypassing the medial prescription requirement.

2 Discussion & conclusions Limited information (short time series) Small number of cases Large countries and countries having issues with medicines-related harm are missing in this survey Different trends in different countries. Trend profiles similar both considering absolute numbers and percentages of cases among DRD Different age profiles of the tramadol-related deaths across countries Apparently no recent change in regulations / availability of tramadol (except in Latvia) Standard Table Toxicology reporting should be encouraged

26 Some comments Some updates of previously reported numbers Finland now there were 24 cases in 29 instead of 16, 3 in 21 vs 27, 23 in 211 vs 18, 21 in 212 vs 18; I Austria in 28 now result 7 cases in 28 instead of ; Latvia in 212 now instead of 2 Lithuania in 212 now instead of 1 Ireland: data from NDRDI For some questionnaires, we may ask you some clarifications and tables filled in, where possible Some analyses limited to the countries with at least 1 cases

27 Ackowledgements To the national experts and or focal points who contributed with data analysis and comments To João Matias who did the analysis of the previous survey

United Kingdom trends in the number of tramadol-related deaths 28 3 2 2 1 1 2 1 37 32 Number of cases in UK GMRs (Deaths registerd in a year) Number of cases in SR (np-sad) (Deaths occurring in a year) 4 19 1 6 36 46 7 3 19 76 To be updated 116 126 83 79 13 18 114 113 2 21 22 23 24 2 26 27 28 29 21 211 212 2 16 24 16

29 United Kingdom age and gender profile of the tramadol-related deaths, 212 (n=11) 4-49 6-64 4-44 >=6-9 3-39 -4 2-24 3-34 2-29 1-19 <1 To be updated 61% males Mean age 43, years (male 43, female ) Female Male -1-1 - 1 1 Number of deaths reported